Proceedings of the National Academy of Sciences, Volume 122, Issue 26, July 2025. <br/>SignificanceThe steroidogenic enzyme 3β-hydroxysteroid dehydrogenase type 1 (3βHSD1) correlates with tumor aggressiveness, and its inhibitors, biochanin-A (BCA) and the related analogs, have shown antitumor activities in various preclinical models and …
